With defined roles in mutagenesis, A3B is reported to promote both initiation and progression of cancer, and overexpression of A3B is usually associated with poor clinical outcomes of cancer patients [7–9], including primary head/neck mucosal melanomas (MMs) [10]. This evidence concerns the gene APOBEC3B and cancer.